Giulia Benevolo

7.0k total citations
54 papers, 1.2k citations indexed

About

Giulia Benevolo is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Giulia Benevolo has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 29 papers in Hematology and 21 papers in Molecular Biology. Recurrent topics in Giulia Benevolo's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers), Multiple Myeloma Research and Treatments (17 papers) and Lymphoma Diagnosis and Treatment (13 papers). Giulia Benevolo is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers), Multiple Myeloma Research and Treatments (17 papers) and Lymphoma Diagnosis and Treatment (13 papers). Giulia Benevolo collaborates with scholars based in Italy, United States and France. Giulia Benevolo's co-authors include Mario Boccadoro, Patrizia Falco, Pellegrino Musto, Antonio Palumbo, Vincenzo Callea, Federica Cavallo, Tommaso Caravita, Francesca Gay, Sara Bringhen and Anna Marina Liberati and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Giulia Benevolo

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giulia Benevolo Italy	15	846	658	511	436	220	54	1.2k
Jean-Paul Fermand France	11	735 0.9×	1.2k 1.8×	674 1.3×	209 0.5×	210 1.0×	13	1.6k
Kamel Laribi France	17	604 0.7×	336 0.5×	321 0.6×	606 1.4×	329 1.5×	62	1.2k
Nathalie Cambier France	14	615 0.7×	385 0.6×	725 1.4×	235 0.5×	138 0.6×	41	1.1k
Jamile M. Shammo United States	17	874 1.0×	429 0.7×	587 1.1×	305 0.7×	227 1.0×	79	1.5k
Michele Merli Italy	17	286 0.3×	303 0.5×	705 1.4×	329 0.8×	474 2.2×	64	1.1k
Marek Hus Poland	17	461 0.5×	366 0.6×	239 0.5×	319 0.7×	87 0.4×	110	869
Francesc Cobo Spain	18	352 0.4×	266 0.4×	650 1.3×	367 0.8×	573 2.6×	38	1.2k
Vesselina Goranova‐Marinova Bulgaria	14	686 0.8×	307 0.5×	473 0.9×	331 0.8×	351 1.6×	44	1.1k
M. A. Gertz United States	10	463 0.5×	628 1.0×	219 0.4×	263 0.6×	88 0.4×	19	932
Nikolaos Anagnostopoulos Greece	17	753 0.9×	513 0.8×	576 1.1×	474 1.1×	456 2.1×	41	1.3k

Countries citing papers authored by Giulia Benevolo

Since Specialization

Citations

This map shows the geographic impact of Giulia Benevolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Benevolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Benevolo more than expected).

Fields of papers citing papers by Giulia Benevolo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Benevolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Benevolo. The network helps show where Giulia Benevolo may publish in the future.

Co-authorship network of co-authors of Giulia Benevolo

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Benevolo. A scholar is included among the top collaborators of Giulia Benevolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Benevolo. Giulia Benevolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Merlini, Giampaolo, Shayna Sarosiek, Giulia Benevolo, et al.. (2023). Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström's Macroglobulinemia on Management of Waldenström's Macroglobulinemia Related Amyloidosis. Seminars in Hematology. 60(2). 113–117. 7 indexed citations

Treon, Steven P., Alessandra Tedeschi, Jesús F. San Miguel, et al.. (2023). Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria. Seminars in Hematology. 60(2). 97–106. 23 indexed citations

Benevolo, Giulia, Monia Marchetti, Remo Melchio, et al.. (2023). Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera. Vascular Health and Risk Management. Volume 19. 765–778. 5 indexed citations

Dogliotti, Irene, Davide Bertuzzo, Giulia Benevolo, et al.. (2022). Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up. European Journal of Neurology. 29(12). 3611–3622. 9 indexed citations

Barreca, Antonella, M. Giarin, Angelo Attanasio, et al.. (2021). Immunohistochemical typing of amyloid in fixed paraffin-embedded samples by an automatic procedure: Comparison with immunofluorescence data on fresh-frozen tissue. PLoS ONE. 16(8). e0256306–e0256306. 14 indexed citations

Benevolo, Giulia, et al.. (2021). Polycythemia Vera (PV): Update on Emerging Treatment Options. Therapeutics and Clinical Risk Management. Volume 17. 209–221. 7 indexed citations

Breccia, Massimo, Claudia Baratè, Giulia Benevolo, et al.. (2019). Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice. Annals of Hematology. 99(1). 65–72. 11 indexed citations

Bringhen, Sara, Roberto Mina, Maria Teresa Petrucci, et al.. (2019). Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies. Haematologica. 104(8). 1640–1647. 19 indexed citations

Breccia, Massimo, Luigiana Luciano, Novella Pugliese, et al.. (2019). Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis. Annals of Hematology. 98(8). 1933–1936. 4 indexed citations

10.

Pich, Achille, Ludovica Riera, Paola Francia di Celle, et al.. (2018). JAK2V617F, CALR, and MPL Mutations and Bone Marrow Histology in Patients with Essential Thrombocythaemia. Acta Haematologica. 140(4). 234–239. 4 indexed citations

11.

Breccia, Massimo, Francesca Palandri, Luigiana Luciano, et al.. (2018). Identification and assessment of frailty in older patients with chronic myeloid leukemia and myelofibrosis, and indications for tyrosine kinase inhibitor treatment. Annals of Hematology. 97(5). 745–754. 7 indexed citations

12.

Botto, Barbara, Roberto Passera, Marilena Bellò, et al.. (2018). Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience. Annals of Hematology. 97(9). 1619–1626. 3 indexed citations

13.

Benevolo, Giulia, Annalisa Chiappella, & Umberto Vitolo. (2013). The risk of CNS involvement in aggressive lymphomas in the rituximab era. Expert Review of Hematology. 6(6). 643–652. 1 indexed citations

14.

Tedeschi, Alessandra, Francesca Ricci, Maria Goldaniga, et al.. (2013). Fludarabine, Cyclophosphamide, and Rituximab in Salvage Therapy of Waldenström's Macroglobulinemia. Clinical Lymphoma Myeloma & Leukemia. 13(2). 231–234. 18 indexed citations

15.

Tedeschi, Alessandra, Giulia Benevolo, Marzia Varettoni, et al.. (2011). Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia. Cancer. 118(2). 434–443. 69 indexed citations

16.

Guglielmelli, Tommasina, Sara Bringhen, Francesca Gay, et al.. (2011). Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients. European Journal of Cancer. 47(6). 814–818. 12 indexed citations

17.

Benevolo, Giulia, Michele Spina, Carola Boccomini, et al.. (2010). PROGNOSTIC VALUE OF CEREBROSPINAL FLUID FLOW CYTOMETRY ANALYSIS IN AGGRESSIVE NHL PATIENTS AT HIGH RISK FOR LEPTOMENINGEAL DISEASE: FCM plus MAY PREDICT AN HIGH RISK OF CNS RELAPSE. Haematologica. 95. 286–287. 1 indexed citations

18.

Palumbo, Antonio, Sara Bringhen, Anna Marina Liberati, et al.. (2008). Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial. Blood. 112(8). 3107–3114. 250 indexed citations

19.

Palumbo, Antonio, Maria Teresa Ambrosini, Giulia Benevolo, et al.. (2006). Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma. Blood. 109(7). 2767–2772. 137 indexed citations

20.

Monfardini, S., Savina Aversa, Valerio Zoli, et al.. (2005). Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas. Annals of Oncology. 16(8). 1352–1358. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact